Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. S. Rafii
A Phase II Trial of Huperzine a in Mild to Moderate Alzheimer Disease
Neurology
Neurology
Orolingual Angioedema Associated With ACE Inhibitor Use After rtPA Treatment of Acute Stroke
Neurology
Neurology
Related publications
A Phase 2 Randomized Trial of ELND005, Scyllo-Inositol, in Mild to Moderate Alzheimer Disease
Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
Safety and Efficacy Results of a Phase II Randomized, Placebo-Controlled, Dose-Ranging Study of Elnd005 (Scyllo-Inositol) in Mild-To-Moderate Alzheimer's Disease
Alzheimer's and Dementia
Molecular Neuroscience
Gerontology
Health Policy
Developmental Neuroscience
Mental Health
Epidemiology
Geriatrics
Cellular
Psychiatry
Neurology
MR Spectroscopy for Assessment of Memantine Treatment in Mild to Moderate Alzheimer Dementia
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Effectiveness of Balance Training Exercise in People With Mild to Moderate Severity Alzheimer's Disease: Protocol for a Randomised Trial
BMC Geriatrics
Gerontology
Geriatrics
Ubiquinol Ameliorates Endothelial Dysfunction in Subjects With Mild-To-Moderate Dyslipidemia: A Randomized Clinical Trial
Nutrients
Nutrition
Food Science
Dietetics
Effect of TTP488 in Patients With Mild to Moderate Alzheimer’s Disease
BMC Neurology
Medicine
Neurology
Bapineuzumab for Mild to Moderate Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Trials
BMC Neurology
Medicine
Neurology
